Abbott Laboratories (ABT)
5 MedTech Stocks That Are Poised to Beat the Market in 2025
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices.
My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks
I review here the stocks of six quality companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. Dividend growth investing is not a get-rich-quick strategy, it requires commitment and a long-term mindset. Making a New Year's resolution is a great way to help maintain that mindset. I discuss two scenarios of hypothetical investors who start their journey in 2025. I detail the significant impact a long-term commitment – even without additional investments – can make.
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
A few different elements can make a stock a no-brainer buy. The company could be the leader in its market, or well diversified across various markets.
Growing Biosimilars Business, New Partnerships Support ABT Stock
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Is Abbott Stock Worth Buying at a Discounted P/S Valuation?
Abbott's strong market position, promising growth prospects and consistent share gains make it a compelling pick for investors.
Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note
Abbott (ABT) closed the most recent trading day at $114.76, moving +0.39% from the previous trading session.
Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The latest trading day saw Abbott (ABT) settling at $114.31, representing a +0.07% change from its previous close.
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
My Top 10 Stocks to Buy for 2025
It's that time of year again. I'm not referring to buying gifts and preparing holiday meals -- although that may be part of your agenda too.
4 Healthcare Technology Innovators to Invest in Before the New Year
Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.
Reasons to Retain ABT Stock in Your Portfolio Now
Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning.
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
Abbott completes the world's first leadless pacing procedures in the left bundle branch of the heart.
